mannitol has been researched along with spironolactone in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (72.73) | 18.7374 |
1990's | 1 (3.03) | 18.2507 |
2000's | 1 (3.03) | 29.6817 |
2010's | 7 (21.21) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Cano, N; Di Constanzo, J; Gauthier, A; Millet, Y; Sarrat, P | 1 |
Dirks, JH | 1 |
Hierholzer, K | 1 |
Nisch, G | 1 |
Suki, WN | 1 |
Regal, EM; Schrier, RW | 1 |
Beyer, J; Sebening, F | 1 |
Baethmann, A; Lanksch, W; Schmiedek, P | 1 |
Anderton, JL; Kincaid-Smith, P | 2 |
Ivanov, IP; Shekhtman, MM; Zhav, B | 1 |
Schmidt, P | 1 |
Jick, H | 1 |
Ito, T; Kinouchi, T; Kurosawa, T; Nagasaka, M; Nakamura, K | 1 |
Shanoff, HM | 1 |
Gayet, C; Savoye, B | 1 |
Demling, L | 1 |
Weinreich, J | 1 |
Colucci, CF | 1 |
Gagnon, O; Gertman, PM; Iber, FL | 1 |
Priebe, HJ | 1 |
Guerrero Fernandez-Marcote, JA; Vara Thorbeck, R | 1 |
Mannermaa, JP; Schipper, NG; Thompson, DO; Tötterman, AM | 1 |
RUYTERS, L | 1 |
McLAREN, JR; SHALDON, S; SHERLOCK, S | 1 |
Chi, JF; Guo, HY; Lee, JD; Ueda, T; Uzui, H | 1 |
Aliaga, S; Chantala, K; Clark, RH; Herring, AH; Hornik, CP; Hughes, R; Laughon, MM; Smith, PB | 1 |
Balogh, DB; Fekete, A; Genovese, F; Hodrea, J; Hosszu, A; Koszegi, S; Lakat, T; Lenart, L; Molnar, A; Sparding, N; Szabo, AJ; Szkibinszkij, E; Vannay, A; Wagner, L | 1 |
4 review(s) available for mannitol and spironolactone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Use of diuretics in nonedematous states.
Topics: Absorption; Bromides; Calcium; Cystinuria; Diuretics; Fanconi Syndrome; Furosemide; Humans; Hypertension; Kidney Tubules; Mannitol; Spironolactone | 1973 |
Diuretics. II. Clinical considerations.
Topics: Administration, Oral; Aminophylline; Ascites; Calcium; Carbohydrate Metabolism; Carbonic Anhydrase Inhibitors; Diabetes Insipidus; Diuretics; Edema; Ethacrynic Acid; Female; Furosemide; Heart Failure; Humans; Hypertension; Hypokalemia; Hyponatremia; Injections, Intravenous; Kidney Failure, Chronic; Liver Cirrhosis; Mannitol; Natriuresis; Nephrotic Syndrome; Organomercury Compounds; Poisoning; Pre-Eclampsia; Pregnancy; Spironolactone; Triamterene; Uric Acid | 1971 |
Diuretics.
Topics: Acetazolamide; Acute Kidney Injury; Chlorothiazide; Diuretics; Diuretics, Osmotic; Ethacrynic Acid; Furosemide; Glomerular Filtration Rate; Humans; Kidney Tubules, Distal; Kidney Tubules, Proximal; Loop of Henle; Mannitol; Spironolactone; Triamterene | 1984 |
29 other study(ies) available for mannitol and spironolactone
Article | Year |
---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
[Letter: The treatment of brain edema during hepatic coma].
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Brain Edema; Female; Hepatic Encephalopathy; Hepatitis A; Humans; Jaundice; Male; Mannitol; Spironolactone; Weil Disease | 1975 |
Mechanisms of action and clinical uses of diuretics.
Topics: Amiloride; Animals; Benzothiadiazines; Calcium; Carbonic Anhydrase Inhibitors; Diuretics; Dogs; Edema; Ethacrynic Acid; Furosemide; Humans; Kidney Tubules; Kidney Tubules, Distal; Kidney Tubules, Proximal; Loop of Henle; Mannitol; Rabbits; Sodium; Sodium Chloride Symporter Inhibitors; Spironolactone | 1979 |
Modes of action of diuretics.
Topics: Acetazolamide; Amiloride; Animals; Benzothiadiazines; Biological Transport; Canrenoic Acid; Chlorides; Diuresis; Diuretics; Furosemide; Kidney Tubules; Mannitol; Potassium; Rats; Sodium; Sodium Chloride Symporter Inhibitors; Spironolactone; Triamterene | 1978 |
[Prevention of brain edema and dehydrating therapy in acute brain injury].
Topics: Brain; Brain Edema; Brain Injuries; Fructose; Glucose; Mannitol; Osmolar Concentration; Oxygen; Sorbitol; Spironolactone | 1975 |
Influence of aldosterone on sodium, water and potassium metabolism in chronic renal disease.
Topics: Aldosterone; Blood; Blood Urea Nitrogen; Body Water; Creatinine; Desoxycorticosterone; Diet, Sodium-Restricted; Extracellular Space; Feces; Glomerular Filtration Rate; Humans; Hydrocortisone; Kidney Concentrating Ability; Kidney Failure, Chronic; Mannitol; Osmolar Concentration; Plasma Volume; Potassium; Sodium; Spironolactone; Urea; Urine; Vasopressins | 1972 |
[Postoperative use of Aldadiene potassium in patients with alloplastic heart valve prosthesis].
Topics: Acid-Base Equilibrium; Aortic Valve; Bicarbonates; Ethacrynic Acid; Furosemide; Heart Valve Prosthesis; Humans; Mannitol; Mitral Valve; Postoperative Complications; Potassium; Preoperative Care; Sodium; Spironolactone; Water-Electrolyte Balance | 1973 |
Formation and treatment of cerebral edema.
Topics: Aldosterone; Animals; Blood-Brain Barrier; Brain Edema; Brain Injuries; Dexamethasone; Ethacrynic Acid; Furosemide; Humans; Hyperbaric Oxygenation; Hypotension, Controlled; Injections, Intravenous; Mannitol; Sorbitol; Spironolactone; Time Factors | 1974 |
[Comparative assessment of the therapeutic effect of modern nonmercuric diuretics in the edematous syndrome of pregnancy].
Topics: Diuretics; Edema; Female; Furosemide; Humans; Mannitol; Pre-Eclampsia; Pregnancy; Spironolactone | 1971 |
[Diuresis and diuretics].
Topics: Acetazolamide; Acute Disease; Agranulocytosis; Anuria; Biological Transport; Blood Platelet Disorders; Brain Edema; Chlorthalidone; Diuresis; Diuretics; Drug Hypersensitivity; Edema; Ethacrynic Acid; Extracellular Space; Furosemide; Glaucoma; Humans; Hyperaldosteronism; Hypokalemia; Hyponatremia; Kidney Failure, Chronic; Mannitol; Natriuresis; Organomercury Compounds; Prediabetic State; Pulmonary Edema; Skin Diseases; Spironolactone; Thiazines; Triamterene; Water-Electrolyte Balance | 1971 |
Diuretics. I. Physiological and pharmacological considerations.
Topics: Acid-Base Equilibrium; Amiloride; Benzothiadiazines; Carbonic Anhydrase Inhibitors; Diuretics; Ethacrynic Acid; Furosemide; Glomerular Filtration Rate; Humans; Kidney; Kidney Concentrating Ability; Kidney Tubules; Mannitol; Organomercury Compounds; Osmosis; Spironolactone; Triamterene; Water-Electrolyte Balance; Xanthines | 1971 |
The use of glucocorticoids for diuresis in patients with fluid retention not resulting from renal disease.
Topics: Aldosterone; Chlorothiazide; Diuresis; Edema; Glomerular Filtration Rate; Glucocorticoids; Heart Diseases; Humans; Liver Cirrhosis; Mannitol; Methylprednisolone; Natriuresis; Organomercury Compounds; Potassium; Sodium; Spironolactone | 1966 |
The effects of aldosterone and spirolactone on renal sodium and potassium excretion during mannitol diuresis.
Topics: Aldosterone; Alkalies; Animals; Chronic Disease; Diuresis; Dogs; Female; Humans; Injections, Intravenous; Mannitol; Nephritis; Potassium; Sodium; Sodium Chloride; Spironolactone; Water-Electrolyte Balance | 1968 |
Diuretics in cardiac edema--1969.
Topics: Benzothiadiazines; Carbonic Anhydrase Inhibitors; Diuretics; Ethacrynic Acid; Furosemide; Glucocorticoids; Heart Failure; Humans; Kidney; Mannitol; Organomercury Compounds; Sodium; Spironolactone; Sulfonamides; Triamterene; Xanthines | 1969 |
[Current treatment of the edematous ascitic syndrome in alcoholic liver cirrhosis].
Topics: Adrenal Cortex Hormones; Alcoholism; Ascites; Diet Therapy; Diuretics; Edema; Humans; Liver Cirrhosis; Mannitol; Punctures; Spironolactone | 1969 |
[Budd-Chiari syndrome].
Topics: Budd-Chiari Syndrome; Cortisone; Humans; Infusions, Parenteral; Mannitol; Phlebitis; Portacaval Shunt, Surgical; Spironolactone | 1971 |
[Portal hypertension in chronic liver diseases and its therapy].
Topics: Ascites; Chronic Disease; Esophageal and Gastric Varices; Humans; Hypertension, Portal; Liver Cirrhosis; Mannitol; Portacaval Shunt, Surgical; Spironolactone; Splenic Neoplasms; Thrombin | 1969 |
[The combination of corticoids, spironolactone, salidiuretics and mannitol according to a particular schema of treatment of ascitic cirrhosis].
Topics: Adrenal Cortex Hormones; Ascites; Diuretics; Humans; Liver Cirrhosis; Mannitol; Spironolactone; Triamterene | 1966 |
Comparison of oral isosorbide and intravenous mannitol as adjuncts to the diuresis of patients with cirrhosis of the liver.
Topics: Adult; Ascites; Humans; Hydrochlorothiazide; Injections, Intravenous; Isosorbide Dinitrate; Liver Cirrhosis; Mannitol; Middle Aged; Nitrites; Potassium; Sodium; Spironolactone | 1967 |
[Normovolemic hemodilution and cerebral edema].
Topics: Animals; Brain Edema; Dexamethasone; Dogs; Hematocrit; Hemodilution; Intracranial Pressure; Mannitol; Potassium; Sodium; Spironolactone | 1982 |
Intestinal safety of water-soluble beta-cyclodextrins in paediatric oral solutions of spironolactone: effects on human intestinal epithelial Caco-2 cells.
Topics: Administration, Oral; beta-Cyclodextrins; Caco-2 Cells; Cyclodextrins; Diuretics; Humans; Intestines; Mannitol; Microscopy, Fluorescence; Solubility; Solutions; Spironolactone | 1997 |
[HOW TO TREAT CIRRHOTIC ASCITES IN 1963].
Topics: Ascites; Benzothiadiazines; Diet, Sodium-Restricted; Drainage; Humans; Liver Cirrhosis; Mannitol; Mineralocorticoid Receptor Antagonists; Prednisone; Rest; Spironolactone | 1963 |
Resistant ascites treated by combined diuretic therapy (spironolactone, mannitol, and chlorothiazide).
Topics: Aldosterone; Ascites; Chlorothiazide; Diuretics; Mannitol; Mineralocorticoid Receptor Antagonists; Spironolactone | 1960 |
Effects of eplerenone on the activation of matrix metalloproteinase-2 stimulated by high glucose and interleukin-1β in human cardiac fibroblasts.
Topics: Cell Line; Culture Media; Enzyme Activation; Eplerenone; Fibroblasts; Gelatinases; Gene Expression; Glucose; Humans; Interleukin-1beta; Mannitol; Matrix Metalloproteinase 2; Myocardium; Osmolar Concentration; RNA, Messenger; Spironolactone | 2014 |
Diuretic exposure in premature infants from 1997 to 2011.
Topics: Acetazolamide; Amiloride; Bronchopulmonary Dysplasia; Chlorothiazide; Cohort Studies; Diazoxide; Diuretics; Drug Therapy, Combination; Ethacrynic Acid; Female; Furosemide; Humans; Hydrochlorothiazide; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Male; Mannitol; Metolazone; Off-Label Use; Respiration, Artificial; Retrospective Studies; Spironolactone; Thrombocytopenia | 2015 |
RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Line; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial Cells; Eplerenone; Fibroblasts; Fibrosis; Humans; Kidney; Losartan; Male; Mannitol; Mineralocorticoid Receptor Antagonists; Proto-Oncogene Proteins c-sis; Ramipril; Rats, Wistar; Renin-Angiotensin System; Spironolactone | 2019 |